Abbott Gears Up For Q2 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts
Portfolio Pulse from Avi Kapoor
Abbott Laboratories (NYSE:ABT) is set to release its Q2 financial results on July 18, with analysts expecting earnings of $1.10 per share and revenue of $10.37 billion. Recent analyst ratings include a mix of Buy, Overweight, and Equal-Weight ratings with price targets ranging from $107 to $140.
July 18, 2024 | 7:05 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Abbott Laboratories is expected to report Q2 earnings of $1.10 per share and revenue of $10.37 billion. Recent analyst ratings include Buy, Overweight, and Equal-Weight with price targets ranging from $107 to $140.
The upcoming earnings report and recent analyst ratings are likely to positively impact Abbott's stock price in the short term. The expected increase in earnings and revenue, along with predominantly positive analyst ratings, suggest investor confidence.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100